New report on Systemic Fungal Infection Therapeutics Market IndiaNews-Medical.netThis Frost & Sullivan research service titled Systemic Fungal Infection Therapeutics Market India provides an analysis of the current diagnostic and ...Research and Markets: Advances in Diagnostic Tests Facilitate More Targeted ...Earthtimes (press release)all 11 news articles »

Max Neeman International and AMEDON Collaborate to Increase EDC PerformancePR-USA.net (press release)Max Neeman offers a complete Data Management & Biostatistical solution to the clinical research/pharmaceutical industry. The approach is to fulfill client ...

Budget 2010: Hits & misses for Pharmaceutical industryEconomic TimesSome of the unaddressed needs like, tax benefits to Clinical Research Organisations, relaxing conditions to claim weighted deduction under the current ...and more »

Cabinet approves proposal to setup Andaman & Nicobar Ports TrustAll India RadioThe existing clinical research units in Siddha at Chennai, Puducherry, Palayam, Kottai, Thiruvananthapuram and the units at Mettur will be brought under the ...and more »

Max Neeman International and AMEDON Collaborate to Increase EDC PerformancePR Newswire (press release)Max Neeman offers a complete Data Management & Biostatistical solution to the clinical research/pharmaceutical industry. The approach is to fulfill client ...and more »

Medical & Scientific Content Writing Workshop on 20th &21st March 2010 at ...PRLog.Org (press release)This task requires deep understanding of regulatory /scientific guidelines involves liaising with many different stakeholders such as clinical research ...

Indian flu kit better than WHO unitTimes of IndiaBANGALORE: Scientists of the Defence Research & Development Organisation and Indian Council of Medical Research claim the H1N1 flu testing kit they have ...and more »

Asia Pharm R&D 2010 - New CRO Trends Become Focus of IndustryPR Newswire (press release)The representative from Transhorsa Translation Ltd. (supporter to the whole translation process) describes this event as a milestone in clinical research ...and more »

Pharmaceutical Technology MagazineReinvigorating European R&D innovationPharmaceutical Technology Magazine6 The most common factors for failure were lack of efficacy (25%), clinical safety concerns (12%) and toxicological findings in preclinical evaluation (20%) ...and more »

Health gets a strong dose of fundsTimes of IndiaBiotech bets: The hike in weighted deduction on in-house R&D expenditure from 150% to 200%, the inclusion of expenses on clinical trials and product patent ...Life sciences sector calls duty rationalisation and infrastructure status in ...pharmabiz.comall 38 news articles »